Table 1.
Sequencing confirmed clinical samples and isolates used for validating specificity
| Organisms | No. of clinical samples | No. of isolates | Total |
|---|---|---|---|
| Target strains used to test the specificity N=303 | |||
| Herpes simplex virus types 1 | 19 | 2 | 21 |
| Herpes simplex virus types 2 | 23 | 0 | 23 |
| Chlamydia trachomatis | 30 | 0 | 30 |
| Treponema pallidum | 16 | 0 | 16 |
| Neisseria gonorrhoeae | 18 | 26 | 44 |
| Trichomonas vaginalis | 18 | 0 | 18 |
| Mycoplasma hominis | 35 | 0 | 35 |
| Ureaplasma urealyticum | 41 | 0 | 41 |
| Mycoplasma genitalium | 27 | 0 | 27 |
| Ureaplasma parvum | 48 | 0 | 48 |
| Haemophilus ducreyi | 0 | 0 | 0 |
| Other species used to test the specificity N=65 | |||
| Human Immunodeficiency Virus | 15 | 1 | 16 |
| Human papillomavirus types 6 | 2 | 0 | 2 |
| Human papillomavirus types 11 | 2 | 0 | 2 |
| Human papillomavirus types 16 | 3 | 0 | 3 |
| Human papillomavirus types 18 | 3 | 0 | 3 |
| Human papillomavirus types 31 | 2 | 0 | 2 |
| Human papillomavirus types 33 | 3 | 0 | 3 |
| Human papillomavirus types 45 | 1 | 0 | 1 |
| Human papillomavirus types 52 | 2 | 0 | 2 |
| Human papillomavirus types 58 | 2 | 0 | 2 |
| Neisseria lactamica | 0 | 4 | 4 |
| Neisseria polysaccharea | 0 | 5 | 5 |
| Neisseria meningitidis | 0 | 2 | 2 |
| Moraxella catarrhalis | 3 | 1 | 4 |
| Klebsiella pneumoniae | 3 | 1 | 4 |
| Mycoplasma pneumoniae | 2 | 1 | 3 |
| Pseudomonas aeroginosa | 2 | 1 | 3 |
| Staphylococcus aureus | 3 | 1 | 4 |